|
WO2021031952A1
|
|
Oxygen-substituted six-membered ring pyrimidine compound, preparation method and medical use thereof
|
|
CN112110918A
|
|
Spiro-substituted pyrimido-cyclic compounds, preparation method and medical application thereof
|
|
CN112047937A
|
|
Tetrahydropyrido [3,4-d ] pyrimidin-2 (1H) -ones, preparation method and medical application thereof
|
|
WO2020244612A1
|
|
Polymorph of cdk9 inhibitor and preparation method for polymorph and use thereof
|
|
WO2020224656A1
|
|
Bisheterocyclic carbonyl substituted dihydropyrazole compound, preparation method therefor and pharmaceutical use thereof
|
|
WO2020221239A1
|
|
Oxaazaquinazoline-7(8h)-ketone compound, preparation method therfor and pharmaceutical application thereof
|
|
WO2020192562A1
|
|
Substituted heterocyclic amide compound and preparation method therefor and pharmaceutical use thereof
|
|
WO2020177629A1
|
|
Spiro-substituted pyrimidine-fused cyclic compound, preparation method therefor and medical use thereof
|
|
WO2019114792A1
|
|
Crystal form and salt form of tgf-βri inhibitor and preparation method therefor
|
|
US2020078343A1
|
|
Inhibitor of cyclin-dependent kinase CDK9
|
